ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 1171

$703K Total Retail Price of All Prescriptions

Rank: 98 out of 1171

502 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

3% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 11,364 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 710 653 1 1
AMLODIPINE BESYLATE 536 522 2 2
LISINOPRIL 418 391 3 3
METOPROLOL SUCCINATE 410 409 4 17
OMEPRAZOLE 384 360 5 5
HYDROCHLOROTHIAZIDE 361 353 6 9
LEVOTHYROXINE SODIUM 346 320 7 4
ATORVASTATIN CALCIUM 333 320 8 10
METOPROLOL TARTRATE 279 279 9 11
LOSARTAN POTASSIUM 274 267 10 14
CITALOPRAM HBR 251 237 11 22
WARFARIN SODIUM 238 232 12 12
CRESTOR 213 207 13 27
FUROSEMIDE 207 206 14 6
METFORMIN HCL 203 200 15 7
TRAMADOL HCL 155 140 16 18
TAMSULOSIN HCL 148 148 17 28
ATENOLOL 147 143 18 15
NEXIUM 144 138 19 25
ALLOPURINOL 138 134 20 31
POTASSIUM CHLORIDE 135 132 21 19
DIOVAN 135 135 21 32
GABAPENTIN 134 124 23 16
PRAVASTATIN SODIUM 129 119 24 13
GLIMEPIRIDE 128 128 25 34
ISOSORBIDE MONONITRATE ER 126 126 26 44
KLOR-CON M20 106 86 27 41
BISOPROLOL FUMARATE 99 99 28 235
FLUTICASONE PROPIONATE 97 82 29 30
SERTRALINE HCL 92 81 30 23
CLONIDINE HCL 88 86 31 45
DOXAZOSIN MESYLATE 87 87 32 82
PAROXETINE HCL 87 68 32 62
PANTOPRAZOLE SODIUM 84 82 34 29
PREDNISONE 82 79 35 39
HYDRALAZINE HCL 82 82 35 60
SYNTHROID 76 76 37 48
BENAZEPRIL HCL 73 73 38 83
NIFEDIPINE ER 69 69 39 114
ZOLPIDEM TARTRATE 69 69 39 21
PROAIR HFA 68 53 41 49
LANTUS 68 68 41 46
CARVEDILOL 67 45 43 20
LOSARTAN-HYDROCHLOROTHIAZIDE 66 66 44 40
COMBIVENT 66 66 44 152
DIGOXIN 64 60 46 68
SPIRONOLACTONE 63 58 47 53
TRIAMTERENE-HCTZ 60 60 48 58
RANITIDINE HCL 60 55 48 38
LOVASTATIN 59 47 50 36
MELOXICAM 57 54 51 56
GLIPIZIDE 55 53 52 47
NITROSTAT 54 51 53 180
SPIRIVA 53 53 54 57
DONEPEZIL HCL 53 53 54 24
CLOPIDOGREL 52 50 56 35
GLYBURIDE 51 51 R 57 97
ALENDRONATE SODIUM 50 50 58 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.